Cross-talk between phospholipase D and MAP kinases activities

Advances in Enzyme Regulation

Volumn 50, Issue 1, 2010, Pages 57-61

  Wakelam, Michael J O ^a   McNee, Gavin S ^a   Rudge, Simon A ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE D;

ANIMAL; ARTICLE; ENZYME ACTIVATION; GENETICS; HELA CELL; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME ACTIVATION; HELA CELLS; HUMANS; ISOENZYMES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASE D; SIGNAL TRANSDUCTION;

EID: 77955284821     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.10.032     Document Type: Article

References (23)

1. 2+ triggered membrane association with selectivity for interaction with phosphatidic acid. Journal of Biological Chemistry 2002, 277:28298-28309.
2. Bechoua S., Daniel L.W. Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine. Journal of Biological Chemistry 2001, 276:31752-31759.
3. Delon C., Manifava M., Wood E., Thompson D., Krugmann S., Pyne S., et al. Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. Journal of Biological Chemistry 2004, 279:44763-44774.
4. Du G., Altshuller Y.M., Kim Y., Han J.M., Ryu S.H., Morris A.J., et al. Dual requirement for Rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signalling. Molecular Biology of the Cell 2000, 11:4359-4368.
5. Exton J.H. Phospholipase D - structure, regulation and function. Reviews of Physiology Biochemistry and Pharmacology 2002, 144:1-94.
6. Frank S., Upender S., Hansen S.H., Casanova J.E. ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor 6. Journal of Biological Chemistry 1998, 273:23-27.
7. Hodgkin M.N., Masson M.R., Powner D.P., Saqib K.M., Ponting C.P., Wakelam M.J.O. Phospholipase D regulation and localisation is dependent upon a phosphatidylinositol 4,5-bisphosphate-specific PH domain. Current Biology 2000, 10:43-46.
8. Ishihara H., Shibasaki Y., Kizuki N., Katagiri H., Yazaki Y., Asano T., et al. Type 1 phosphatidylinositol-4-phosphate 5 kinases. Cloning of the third isoforms and deletion/substitution analysis of members of this novel lipid kinase family. Journal of Biological Chemistry 1998, 273:8741-8748.
9. Kim S.Y., Ahn B.-H., Min K.-J., Lee Y.H., Joe E.-H., Min D.S. Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells. Journal of Biological Chemistry 2004, 279:38125-38133.
10. Li F., Malik K.U. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. Journal of Pharmacology and Experimental Therapeutics 2005, 312:1043-1054.
11. McDermott M., Wakelam M.J.O., Morris A.J. Phospholipase D. Biochemistry and Cell Biology 2004, 82:225-253.
12. Natarajan V., Scriber W.M., Morris A.J., Roy S., Vepa S., Yang J., et al. Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells. American Journal of Physiology 2001, 281:L435-L449.
13. Nishikimi A., Fukuhara H., Su W., Hongu T., Takasuga S., Mihara H., et al. Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science 2009, 324:384-387.
14. Ozanne B.W., Spence H.J., McGarry L.C., Hennigan R.F. Transcription factors control invasion: AP-1 the first among equals. Oncogene 2007, 26:1-10.
15. Powner D.J., Hodgkin M.N., Wakelam M.J.O. Antigen-stimulated activation of phospholipase D1b by Rac1, ARF6 and PKCα in RBL2H3 cells. Molecular Biology of the Cell 2002, 13:1252-1262.
16. Powner D.J., Payne R.M., Pettitt T.R., Giudici M.L., Irvine R.F., Wakelam M.J.O. Phospholipase D2 stimulates integrin-mediated adhesion via phosphatidylinositol 4-phosphate 5-kinase IΥ{hooked} b. Journal of Cell Science 2005, 118:2975-2986.
17. Rizzo M.A., Shome K., Vasudevan C., Stolz D.B., Sung T.C., Frohman M.A., et al. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. Journal of Biological Chemistry 1999, 274:1131-1139.
18. Rudge S.A., Wakelam M.J.O. Inter-regulatory dynamics of phospholipase D and the actin cytoskeleton. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009, 1791:856-861.
19. Sciorra V.A., Rudge S.A., Prestwich G.D., Frohman M.A., Engebrecht J.A., Morris A.J. Identification of phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes. EMBO Journal 1999, 18:5911-5921.
20. Scott S.A., Selvy P.E., Buck J.R., Cho H.P., Criswell T.L., Thomas A.L., et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nature Chemical Biology 2009, 5:108-117.
21. Stahelin R.V., Ananthanarayanan B., Blatner N.R., Singh S., Bruzik K.S., Murray D., et al. Mechanism of membrane binding of the phospholipase D1 PX domain. Journal of Biological Chemistry 2004, 279:54918-54926.
22. van Dam H., Castellazzi M. Distinct roles of Jun:Fos and Jun:ATF homodimers in oncogenesis. Oncogene 2001, 20:2453-2464.
23. Varadharaj S., Steinhour E., Hunter M.G., Watkins T., Baran C.P., Magalang U., et al. Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: regulation by MAP kinases. Cellular Signalling 2006, 18:1396-1407.